These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk? Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150 [TBL] [Abstract][Full Text] [Related]
4. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors. Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322 [TBL] [Abstract][Full Text] [Related]
5. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans. Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936 [TBL] [Abstract][Full Text] [Related]
6. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy. Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404 [TBL] [Abstract][Full Text] [Related]
7. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136 [TBL] [Abstract][Full Text] [Related]
8. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors. Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy. Xhaferllari I; El-Sherif O; Gaede S J Appl Clin Med Phys; 2016 Sep; 17(5):329-340. PubMed ID: 27685129 [TBL] [Abstract][Full Text] [Related]
10. Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR. Kazemzadeh N; Modiri A; Samanta S; Yan Y; Bland R; Rozario T; Wibowo H; Iyengar P; Ahn C; Timmerman R; Sawant A Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):210-218. PubMed ID: 29891202 [TBL] [Abstract][Full Text] [Related]
11. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Liu H; Zhang X; Vinogradskiy YY; Swisher SG; Komaki R; Chang JY Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1017-23. PubMed ID: 22543216 [TBL] [Abstract][Full Text] [Related]
12. The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. Shultz DB; Jang SS; Hanlon AL; Diehn M; Loo BW; Maxim PG Pract Radiat Oncol; 2014; 4(3):192-197. PubMed ID: 24766687 [TBL] [Abstract][Full Text] [Related]
13. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy. Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy. Sanford L; Molloy J; Kumar S; Randall M; McGarry R; Pokhrel D J Appl Clin Med Phys; 2019 Jan; 20(1):118-127. PubMed ID: 30548205 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy. Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284 [TBL] [Abstract][Full Text] [Related]
16. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy. Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867 [TBL] [Abstract][Full Text] [Related]
17. Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer. Hardcastle N; Cook O; Ray X; Moore A; Moore KL; Pryor D; Rossi A; Foroudi F; Kron T; Siva S Radiat Oncol; 2021 Aug; 16(1):142. PubMed ID: 34344402 [TBL] [Abstract][Full Text] [Related]
18. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation. Ren C; Ji T; Liu T; Dang J; Li G Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer. Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078 [TBL] [Abstract][Full Text] [Related]
20. Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy. Tekatli H; Tetar SU; Nguyen TK; Warner A; Verbakel WF; Palma DA; Dahele M; Gaede S; Haasbeek C; Spoelstra FO; de Haan PF; Slotman BJ; Senan S Acta Oncol; 2017 Apr; 56(4):548-554. PubMed ID: 28358667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]